Background
==========

Patients with dysglycemia at the time of ST-elevation myocardial infarction (STEMI) have a worse prognosis. The reasons for this are not entirely clear. Admission hyperglycemia has been associated with larger infarct size.

The aims of this study were to examine the relation of acute and chronic glycemic state to myocardial scar and salvage characteristics in patients with reperfused ST-elevation myocardial infarction.

Methods
=======

56 patients treated for first ST-elevation myocardial infarction (STEMI) without a known diagnosis of Diabetes mellitus were prospectively enrolled between January and December 2010. Glycosylated hemoglobin (HbA1c) and glucose were sampled on admission to the emergency cardiac ward. Patients underwent CMR during the index admission (median day 2, IQR 2days), with assessment of area-at-risk (STIRs), Infarct size%, late microvascular obstruction, and left ventricular function. Population characteristics are presented in Table [1](#T1){ref-type="table"}.

###### 

Patient characteristics

  Age (years)                                                         60.77 +/- 11.75
  ------------------------------------------------------------------- -------------------------------------------------------------------------
  Male                                                                50/56 (89%)
                                                                      
  Peak CK (U/l)                                                       1318.8 +/- 1282
                                                                      
  Hypertension                                                        20/56 (36%)
                                                                      
  Smoking                                                             28/56 (50%)
                                                                      
  Hypercholesterolemia                                                15/56 (27%)
                                                                      
  Family history                                                      17/56 (30%)
                                                                      
  Diabetes Mellitus                                                   0/56 (0%)
                                                                      
  Reperfusion therapy: PPCI thrombolysis                              45 (80%) 11 (20%)
                                                                      
  Time to reperfusion (minutes) all patients PPCI only thrombolysis   194.16 +/- 121.12 (140) 189.36 +/- 113.86 (120) 213.82 +/- 152.04 (225)
                                                                      
  Multivessel disease                                                 22/56 (39%)
                                                                      
  LAD culprit                                                         25/56(45%)
                                                                      
  Glucose (mmol/l)                                                    7.97 +/- 2.54 (median 7.7, IQR 2.10)
                                                                      
  HbA1c (%)                                                           6.67 +- 1.07 (median 5.9, IQR 2.10)
                                                                      
  IS% by FWHM                                                         23.08 +/- 12.97 (median 20.31, IQR 16.68)
                                                                      
  MVO%                                                                2.02 +/- 3.67 (median 0.49, IQR 3.01)
                                                                      
  AAR%                                                                41.19 +/- 13.78 (median 38.78, IQR 22.21)
                                                                      
  MSI%                                                                53.71 +/- 26.41 (median 58.96, IQR 35.09)
                                                                      
  ECG resolution%                                                     62% +/- 34% (median 67%)

PPCI= Primary Percutaneous Coronary Intervention, LAD= Left Anterior Descending Coronary Artery, IS=Infarct size, MVO=microvascular obstruction, IMH=intramyocardial hemorrhage, AAR=Area at risk, MSI= Myocardial Salvage Index.

###### 

Correlations between infarct characteristics and glucose characteristics:

                        Glucose            HbA1c
  --------------------- ------------------ ------------------
  Peak CK               R=0.152 P=0.267    R=0.120 P=0.393
                                           
  ECG resolution %      R=-0.393 P=0.003   R=-0.352 P=0.010
                                           
  Time to reperfusion   R=0.185 P=0.177    R=0.334 P=0.015
                                           
  Age                   R=0.361 P=0.007    R=0.184 P=0.188
                                           
  IS%                   R=0.296 P=0.028    R=0.152 P=0.277
                                           
  MVO%                  R=0.259 P=0.056    R=0.199 P=0.152
                                           
  IMH%                  R=0.187 P=0.176    R=0.292 P=0.036
                                           
  AAR%                  R=0.128 P=0.358    R=-0.176 P=0.213
                                           
  MSI%                  R=-0.187 P=0.176   R=-0.399 P=0.003

IS=Infarct size, MVO=microvascular obstruction, IMH=intramyocardial hemorrhage, AAR=Area at risk, MSI= Myocardial Salvage Index.

Patients with below and above median glucose were compared. Spearman\'s rank correlation was used to compare non-parametric data. Correlations with a p\<0.1 were entered into a multivariate linear regression model. Independent t-tests were used to compare groups above and below the median for glucose and HbA1c levels. There were no significant differences between patients receiving PPCI or thrombolysis, so these were grouped for analysis.

Results
=======

When patients were dichotomised into glucose levels below (\<7.8) and above the median (≥7.8), the supra-median group were significantly older (64.7 years vs. 57.1 years, p=0.018) and had greater infarct size (28.33% vs. 18.46%, p=0.007).

Dichotomising patients by HbA1c into levels below the median (\<5.9%) and above the median (≥5.9%), the supra-median group had significantly greater glucose levels (8.8 mmol/l vs. 7.1mmol/l, p=0.010), lower ECG resolution (51.6% vs. 75.5%, p=0.018), greater MVO% (2.77% vs. 1.11%, p=0.049), greater IMH% (1.96% vs. 0.61%, =-0.015), and lower myocardial salvage index (43.30% vs. 65.15%, p=0.003).

On multivariate linear regression analysis however, glucose was not a predictor of IS% (R=0.549, R2=0.302, Age t=3.441, p=0.001, time to reperfusion t=2.708, p=0.009, glucose- NS), and HbA1c was not a predictor of MSI% (R=0.453, R2=0.206, age t=-2.529, p=0.015, time to reperfusion t=-2.237, p=0.030, HbA1c-NS).

Conclusions
===========

Admission glucose levels are associated with larger infarct size, and HbA1c levels are associated with reduced myocardial salvage. However, glycemic status is not an independent predictor of infarct size or salvage when time to reperfusion is taken in to consideration.
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